+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biological Safety Testing Products & Services Market - Global Forecast 2026-2032- Product Image
Biological Safety Testing Products & Services Market - Global Forecast 2026-2032- Product Image
Sale

Biological Safety Testing Products & Services Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011396
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biological Safety Testing Products & Services Market is projected to reach USD 7.78 Billion in 2026. It is expected to continue growing at a CAGR of 11.51%, reaching USD 14.98 Billion by 2032.

Biological safety testing products and services are central to demonstrating that biologics, vaccines, cell and gene therapies, medical devices, and critical raw materials meet global expectations for patient safety, product quality, and contamination control. The field is anchored in validated assays for sterility, bioburden, bacterial endotoxins, mycoplasma, adventitious viruses, residual host-cell DNA and proteins, cytotoxicity, sensitization, irritation, systemic toxicity, hemocompatibility, and related biological risk endpoints.

Demand is being reinforced by expanding biologics pipelines, wider adoption of advanced therapies, increased use of single-use systems, and tighter expectations for microbiological control across development and manufacturing. Regulatory and standards frameworks, including USP chapters, ISO 10993, ICH Q5A(R2), ICH Q5D, ICH Q6B, EU GMP Annex 1, FDA biologics guidance, and WHO recommendations, continue to define the evidence base for biological safety testing services and validated testing products.

Transformative Shifts in the Biological Safety Testing Landscape

The biological safety testing landscape is shifting from traditional end-point quality control toward risk-based, lifecycle-oriented safety assurance. Regulators increasingly expect manufacturers to demonstrate contamination control across raw materials, cell substrates, process intermediates, facilities, utilities, single-use assemblies, packaging components, and final products rather than relying only on release testing.

Rapid microbiological methods, recombinant endotoxin reagents, nucleic acid amplification tests, next-generation sequencing, automated environmental monitoring, digital batch records, and high-throughput analytical platforms are changing how laboratories detect and manage biological risks. At the same time, outsourcing to specialist contract testing organizations is rising as sponsors seek access to validated methods, biosafety expertise, global compliance knowledge, and scalable laboratory capacity while preserving auditability and data integrity.

Cumulative Impact of Artificial Intelligence on Testing Workflows

Artificial intelligence is beginning to influence biological safety testing through laboratory automation, image analytics, anomaly detection, predictive contamination control, electronic data review, and in silico toxicology support. Publications and discussion papers from major health authorities on artificial intelligence, software assurance, and good machine learning practice emphasize that these tools must remain transparent, validated, monitored, and fit for their intended use.

The cumulative impact of AI is strongest where it improves repeatability, traceability, and data integrity, including colony counting, environmental monitoring trend analysis, deviation triage, laboratory scheduling, and quality-system surveillance. However, AI does not replace validated biological assays; it strengthens decision-making when paired with qualified methods, human scientific oversight, audit trails, cybersecurity controls, change management, and regulatory-ready documentation.

Key Regional Insights Across Global Biological Safety Testing Markets

Asia-Pacific is becoming a major growth engine as China, India, Japan, South Korea, Singapore, and Australia expand biomanufacturing, vaccine production, biosimilar development, and clinical research capacity under increasingly mature regulatory systems. The region’s demand for biological safety testing products and services is supported by national biopharma strategies, investments in advanced therapy infrastructure, and adoption of international standards for sterility, endotoxin, mycoplasma, adventitious agent, and biocompatibility testing.

North America remains a benchmark for biologics quality expectations because of FDA and Health Canada oversight, advanced contract testing infrastructure, and a high concentration of innovative drug developers, medical device manufacturers, and advanced therapy programs. Latin America is gaining relevance as Brazil and Mexico strengthen pharmaceutical manufacturing, clinical research participation, and health authority oversight, with Brazil’s regulatory framework widely recognized for its maturity in the region.

Europe benefits from EMA coordination, EU GMP Annex 1, the Medical Device Regulation, the In Vitro Diagnostic Regulation, national competent authorities, and strong reference laboratory networks, making the region highly influential in biological safety, contamination control, and biocompatibility standards. The Middle East is building local life science capacity through healthcare localization programs, GCC regulatory modernization, and hospital-linked research investments, while Africa is prioritizing vaccine security, diagnostics, and public health laboratory capability with support from Africa CDC, WHO, and regional manufacturing initiatives.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are advancing biological safety testing demand through pharmaceutical regulatory harmonization, expanding clinical trials, and government support for local vaccine, biosimilar, and sterile manufacturing capacity. These dynamics increase the need for compliant sterility testing, bioburden testing, endotoxin testing, cell substrate characterization, viral safety evaluation, and medical device biological evaluation across regional supply chains.

The GCC is investing in healthcare localization, biologics access, national medicine security, and regulatory modernization, creating opportunities for microbiology, endotoxin, sterility, and device biocompatibility testing partners that can align with international standards. The European Union provides one of the most structured compliance environments through EMA scientific guidelines, EU GMP Annex 1, MDR, IVDR, pharmacovigilance systems, and harmonized quality expectations across member states.

BRICS countries are strategically important because they combine large patient populations, growing domestic biopharmaceutical capacity, vaccine manufacturing priorities, and increasing regulatory convergence with ICH and WHO-aligned practices. The G7 concentrates many originator biologics developers, advanced testing laboratories, academic research centers, and influential standards-setting bodies, while NATO countries add demand linked to medical readiness, vaccines, diagnostics, biodefense preparedness, emergency stockpiles, and resilient healthcare supply chains.

Key Country Insights Shaping Biological Safety Testing Demand

The United States leads in high-complexity biologics, cell and gene therapy testing, biosafety characterization, and FDA-aligned quality systems, supported by extensive GMP infrastructure and strong demand for validated analytical and microbiological services. Canada supports biologics, vaccine oversight, and clinical research through Health Canada regulation and internationally aligned quality expectations, while Mexico and Brazil serve as important Latin American hubs for pharmaceutical manufacturing, with Mexico integrated into North American supply chains and Brazil’s ANVISA recognized for robust regulatory capability.

The United Kingdom, Germany, France, Italy, and Spain anchor European demand through advanced biopharmaceutical manufacturing, medical technology sectors, academic research ecosystems, and strong GMP enforcement. Germany and France are especially influential in biopharma manufacturing and medical technology, the United Kingdom supports advanced therapy research and regulatory innovation, Italy contributes sterile manufacturing and contract development capabilities, and Spain continues to expand clinical research and biotechnology activity, while Russia maintains domestic vaccine and biologics capabilities under national regulatory oversight.

China continues to scale biologics, biosimilars, vaccines, and cell therapy infrastructure under NMPA reforms and closer alignment with international technical standards. India remains a global supplier of vaccines and biosimilars with CDSCO oversight and a broad biologics manufacturing base; Japan maintains a quality-focused environment under PMDA and MHLW; Australia supports clinical research and TGA-regulated product development; and South Korea has become a global biologics manufacturing and biosimilars powerhouse, supported by strong government backing for biotechnology and high-quality manufacturing systems.

Actionable Recommendations for Industry Leaders

Industry leaders should invest in validated rapid microbiological methods, digital laboratory systems, automation, and harmonized global quality procedures while maintaining alignment with USP, Ph. Eur., ISO, ICH, FDA, EMA, PIC/S, and WHO expectations. Companies should qualify suppliers rigorously, build redundancy for critical reagents and contract testing capacity, and apply contamination-control strategies across the full product lifecycle.

Executives should prioritize data integrity, method comparability, technician training, and early regulatory engagement for novel modalities such as viral vectors, mRNA products, engineered cells, microbiome-based therapies, and combination devices. Partnerships with accredited contract testing organizations can reduce bottlenecks when governed by clear quality agreements, transparent method validation, secure data exchange, deviation escalation procedures, and audit-ready documentation.

Research Methodology and Evidence Base

This executive summary is built from secondary research and regulatory intelligence covering publicly available guidance, pharmacopeial standards, health authority publications, industry quality frameworks, and recognized scientific literature. Sources informing the analysis include FDA, EMA, WHO, ICH, ISO, USP, European Pharmacopoeia, OECD, PIC/S, national health authorities, and documented trends in biologics, vaccines, advanced therapies, and medical device quality systems.

The methodology prioritizes verified, traceable, and compliance-relevant insights rather than unsubstantiated commercial claims. Findings are synthesized through cross-regional comparison of regulatory expectations, manufacturing capacity, technology adoption, outsourcing patterns, contamination-control requirements, and quality-system obligations affecting biological safety testing products and services.

Conclusion: Biological Safety Testing as a Strategic Quality Imperative

Biological safety testing is evolving into a strategic quality function that protects patients, supports regulatory submissions, and strengthens manufacturing resilience. As biologics, advanced therapies, vaccines, biosimilars, and medical devices become more complex, demand will favor providers that combine validated science with speed, compliance, traceability, and global scalability.

Organizations that modernize testing platforms, integrate artificial intelligence responsibly, strengthen supplier qualification, and align with international standards will be better positioned to manage biological risk across the product lifecycle. The strongest competitive advantage will come from defensible data, reliable turnaround times, robust quality systems, and end-to-end biosafety expertise.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biological Safety Testing Products & Services Market, by Product
7.1. Introduction
7.2. Instruments
7.2.1. Biosafety Cabinets
7.2.2. ELISA Instruments
7.2.3. PCR Instruments
7.3. Reagents & Kits
7.3.1. Culture Media
7.3.2. ELISA Reagents & Kits
7.3.3. PCR Reagents & Kits
7.4. Services
7.4.1. Calibration Services
7.4.2. Consulting Services
7.4.3. Validation Services
7.5. Software
7.5.1. Data Management Software
7.5.2. Workflow Automation Software
8. Biological Safety Testing Products & Services Market, by Test
8.1. Introduction
8.2. Bioburden
8.2.1. Plate Count
8.2.2. Rapid Methods
8.3. Endotoxin
8.3.1. LAL Test
8.3.2. rFC Test
8.4. Microbial Identification
8.4.1. MALDI-TOF
8.4.2. PCRBased
8.5. Sterility
8.5.1. Direct Inoculation
8.5.2. Membrane Filtration
9. Biological Safety Testing Products & Services Market, by Technology
9.1. Introduction
9.2. Chromatography
9.3. ELISA
9.4. Mass Spectrometry
9.5. PCR
10. Biological Safety Testing Products & Services Market, by End Use
10.1. Introduction
10.2. Academic & Research
10.3. Biotechnology
10.4. CRO
10.5. Food & Beverage
10.6. Hospitals & Diagnostics
10.7. Pharmaceutical
11. Biological Safety Testing Products & Services Market, by Service Mode
11.1. Introduction
11.2. In House
11.3. Outsourced
12. Biological Safety Testing Products & Services Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Biological Safety Testing Products & Services Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Biological Safety Testing Products & Services Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Asahi Kasei Corporation
16.2. Avance Biosciences Inc.
16.3. BBF Sterilisationsservice GmbH
16.4. BSL Bioservice Scientific Laboratories Munich GmbH
16.5. Charles River Laboratories International, Inc.
16.6. Creative Biogene
16.7. Eurofins Scientific SE
16.8. Labquality Oy
16.9. Lonza Group AG
16.10. Merck KGaA
16.11. North American Science Associates, Inc.
16.12. NuAire, Inc.
16.13. Pace Analytical Services, LLC
16.14. Samsung Biologics
16.15. Sartorius AG
16.16. SGS Société Générale de Surveillance SA
16.17. Thermo Fisher Scientific Inc.
16.18. Toyobo Co., Ltd.
16.19. UL LLC
16.20. ViruSure GmbH
16.21. WuXi Biologics Co., Ltd.
17. Key Experts
List of Figures
FIGURE 1. Global Biological Safety Testing Products & Services Market, Years Considered for the Study
FIGURE 2. Global Biological Safety Testing Products & Services Market, Research Design
FIGURE 3. Global Biological Safety Testing Products & Services Market, Research Framework
FIGURE 4. Global Biological Safety Testing Products & Services Market, Data Triangulation
FIGURE 5. Global Biological Safety Testing Products & Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Biological Safety Testing Products & Services Market Size, by Product, 2025 vs 2032 (%)
FIGURE 7. Global Biological Safety Testing Products & Services Market Size, by Product, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Biological Safety Testing Products & Services Market Size, by Test, 2025 vs 2032 (%)
FIGURE 9. Global Biological Safety Testing Products & Services Market Size, by Test, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Biological Safety Testing Products & Services Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 11. Global Biological Safety Testing Products & Services Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Biological Safety Testing Products & Services Market Size, by End Use, 2025 vs 2032 (%)
FIGURE 13. Global Biological Safety Testing Products & Services Market Size, by End Use, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Biological Safety Testing Products & Services Market Size, by Service Mode, 2025 vs 2032 (%)
FIGURE 15. Global Biological Safety Testing Products & Services Market Size, by Service Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Biological Safety Testing Products & Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Biological Safety Testing Products & Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Biological Safety Testing Products & Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Biological Safety Testing Products & Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Biological Safety Testing Products & Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Biological Safety Testing Products & Services Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Biological Safety Testing Products & Services Market Segmentation & Coverage
TABLE 2. Global Biological Safety Testing Products & Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Biosafety Cabinets Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Biosafety Cabinets Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Biosafety Cabinets Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global ELISA Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global ELISA Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global ELISA Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global PCR Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global PCR Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global PCR Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Reagents & Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Reagents & Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Reagents & Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Culture Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Culture Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Culture Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global ELISA Reagents & Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global ELISA Reagents & Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global ELISA Reagents & Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global PCR Reagents & Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global PCR Reagents & Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global PCR Reagents & Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Calibration Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Calibration Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Calibration Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Consulting Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Consulting Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Consulting Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Validation Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Validation Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Validation Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Data Management Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Data Management Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Data Management Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Workflow Automation Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Workflow Automation Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Workflow Automation Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 50. Global Bioburden Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Bioburden Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Bioburden Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Plate Count Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Plate Count Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Plate Count Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Rapid Methods Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Rapid Methods Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Rapid Methods Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Endotoxin Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Endotoxin Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Endotoxin Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global LAL Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global LAL Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global LAL Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global rFC Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global rFC Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global rFC Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Microbial Identification Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Microbial Identification Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Microbial Identification Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global MALDI-TOF Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global MALDI-TOF Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global MALDI-TOF Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global PCRBased Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global PCRBased Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global PCRBased Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Sterility Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Sterility Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Sterility Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Direct Inoculation Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Direct Inoculation Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Direct Inoculation Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Membrane Filtration Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Membrane Filtration Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Membrane Filtration Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 87. Global Chromatography Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Chromatography Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Chromatography Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 100. Global Academic & Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Academic & Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Academic & Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global CRO Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global CRO Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global CRO Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Food & Beverage Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Food & Beverage Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Food & Beverage Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Hospitals & Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Hospitals & Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Hospitals & Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Pharmaceutical Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Pharmaceutical Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Pharmaceutical Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 119. Global In House Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global In House Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global In House Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Outsourced Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Outsourced Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Outsourced Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Biological Safety Testing Products & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 139. Asia-Pacific Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 140. North America Biological Safety Testing Products & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. North America Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 142. North America Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 143. North America Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 144. North America Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 145. North America Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 146. North America Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 147. North America Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 148. North America Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 149. North America Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 150. North America Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 151. North America Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 152. North America Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 153. North America Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 154. Latin America Biological Safety Testing Products & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Latin America Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 156. Latin America Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 157. Latin America Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 158. Latin America Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 159. Latin America Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 160. Latin America Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 161. Latin America Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 162. Latin America Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 163. Latin America Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 164. Latin America Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 165. Latin America Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 166. Latin America Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 167. Latin America Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 168. Europe Biological Safety Testing Products & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Europe Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 170. Europe Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 171. Europe Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 172. Europe Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 173. Europe Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 174. Europe Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 175. Europe Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 176. Europe Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 177. Europe Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 178. Europe Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 179. Europe Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 180. Europe Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 181. Europe Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 182. Middle East Biological Safety Testing Products & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Middle East Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 184. Middle East Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 185. Middle East Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 186. Middle East Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 187. Middle East Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 188. Middle East Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 189. Middle East Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 190. Middle East Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 191. Middle East Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 192. Middle East Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 193. Middle East Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 194. Middle East Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 195. Middle East Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 196. Africa Biological Safety Testing Products & Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Africa Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 198. Africa Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 199. Africa Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 200. Africa Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 201. Africa Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 202. Africa Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 203. Africa Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 204. Africa Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 205. Africa Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 206. Africa Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 207. Africa Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. Africa Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 209. Africa Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 210. Global Biological Safety Testing Products & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. ASEAN Biological Safety Testing Products & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 212. ASEAN Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 213. ASEAN Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 214. ASEAN Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 215. ASEAN Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 216. ASEAN Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 217. ASEAN Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 218. ASEAN Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 219. ASEAN Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 220. ASEAN Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 221. ASEAN Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 222. ASEAN Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 223. ASEAN Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 224. ASEAN Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 225. GCC Biological Safety Testing Products & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. GCC Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 227. GCC Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 228. GCC Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 229. GCC Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 230. GCC Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 231. GCC Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 232. GCC Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 233. GCC Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 234. GCC Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 235. GCC Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 236. GCC Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. GCC Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 238. GCC Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 239. European Union Biological Safety Testing Products & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 240. European Union Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 241. European Union Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 242. European Union Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 243. European Union Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 244. European Union Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 245. European Union Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 246. European Union Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 247. European Union Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 248. European Union Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 249. European Union Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 250. European Union Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. European Union Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 252. European Union Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 253. BRICS Biological Safety Testing Products & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 254. BRICS Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 255. BRICS Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 256. BRICS Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 257. BRICS Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 258. BRICS Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 259. BRICS Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 260. BRICS Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 261. BRICS Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 262. BRICS Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 263. BRICS Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 264. BRICS Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. BRICS Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 266. BRICS Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 267. G7 Biological Safety Testing Products & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 268. G7 Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 269. G7 Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 270. G7 Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 271. G7 Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 272. G7 Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 273. G7 Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 274. G7 Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 275. G7 Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 276. G7 Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 277. G7 Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 278. G7 Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 279. G7 Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 280. G7 Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 281. NATO Biological Safety Testing Products & Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 282. NATO Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 283. NATO Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 284. NATO Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 285. NATO Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 286. NATO Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 287. NATO Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 288. NATO Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 289. NATO Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 290. NATO Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 291. NATO Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 292. NATO Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 293. NATO Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 294. NATO Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 295. Global Biological Safety Testing Products & Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 296. United States Biological Safety Testing Products & Services Market Size, 2017-2032 (USD Million)
TABLE 297. United States Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 298. United States Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 299. United States Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 300. United States Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 301. United States Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 302. United States Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 303. United States Biological Safety Testing Products & Services Market Size, by Bioburden, 2017-2032 (USD Million)
TABLE 304. United States Biological Safety Testing Products & Services Market Size, by Endotoxin, 2017-2032 (USD Million)
TABLE 305. United States Biological Safety Testing Products & Services Market Size, by Microbial Identification, 2017-2032 (USD Million)
TABLE 306. United States Biological Safety Testing Products & Services Market Size, by Sterility, 2017-2032 (USD Million)
TABLE 307. United States Biological Safety Testing Products & Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 308. United States Biological Safety Testing Products & Services Market Size, by End Use, 2017-2032 (USD Million)
TABLE 309. United States Biological Safety Testing Products & Services Market Size, by Service Mode, 2017-2032 (USD Million)
TABLE 310. Canada Biological Safety Testing Products & Services Market Size, 2017-2032 (USD Million)
TABLE 311. Canada Biological Safety Testing Products & Services Market Size, by Product, 2017-2032 (USD Million)
TABLE 312. Canada Biological Safety Testing Products & Services Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 313. Canada Biological Safety Testing Products & Services Market Size, by Reagents & Kits, 2017-2032 (USD Million)
TABLE 314. Canada Biological Safety Testing Products & Services Market Size, by Services, 2017-2032 (USD Million)
TABLE 315. Canada Biological Safety Testing Products & Services Market Size, by Software, 2017-2032 (USD Million)
TABLE 316. Canada Biological Safety Testing Products & Services Market Size, by Test, 2017-2032 (USD Million)
TABLE 317. Canada Biol

Companies Mentioned

  • Asahi Kasei Corporation
  • Avance Biosciences Inc.
  • BBF Sterilisationsservice GmbH
  • BSL Bioservice Scientific Laboratories Munich GmbH
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Eurofins Scientific SE
  • Labquality Oy
  • Lonza Group AG
  • Merck KGaA
  • North American Science Associates, Inc.
  • NuAire, Inc.
  • Pace Analytical Services, LLC
  • Samsung Biologics
  • Sartorius AG
  • SGS Société Générale de Surveillance SA
  • Thermo Fisher Scientific Inc.
  • Toyobo Co., Ltd.
  • UL LLC
  • ViruSure GmbH
  • WuXi Biologics Co., Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.78 Billion
Forecasted Market Value ( USD ) by 2032 $ 14.98 Billion
Compound Annual Growth Rate11.5%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Biological Safety Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Biological Safety Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 114 Pages
  • Global
From
Biological Safety Testing Market Size, Share, Trends, and Forecast by Product and Services, Test Type, Application, and Region, 2026-2034 - Product Image

Biological Safety Testing Market Size, Share, Trends, and Forecast by Product and Services, Test Type, Application, and Region, 2026-2034

  • Report
  • 149 Pages
  • Global
From
Biological Safety Testing Products and Services Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Services, Instruments), Application (Vaccines & Therapeutics, Gene Therapy, Stem Cell), Test, and Region with Growth Forecasts, 2026-2033 - Product Image

Biological Safety Testing Products and Services Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Services, Instruments), Application (Vaccines & Therapeutics, Gene Therapy, Stem Cell), Test, and Region with Growth Forecasts, 2026-2033

  • Report
  • 136 Pages
  • Global
From
Biological Safety Testing Products and Services Market Report 2026 - Product Image

Biological Safety Testing Products and Services Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Biological Safety Testing Products and Services Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 - Product Image

Biological Safety Testing Products and Services Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

  • Report
  • 185 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.